---
title: "PlainLanguageRx: Improving Medication Labels to Reduce Health Disparities"
nct_id: NCT01622686
overall_status: COMPLETED
phase: NA
sponsor: PictureRx, LLC
study_type: INTERVENTIONAL
primary_condition: Health Behavior
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01622686.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01622686"
ct_last_update_post_date: 2012-06-19
last_seen_at: "2026-05-12T07:04:27.985Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# PlainLanguageRx: Improving Medication Labels to Reduce Health Disparities

**NCT ID:** [NCT01622686](https://clinicaltrials.gov/study/NCT01622686)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 470
- **Lead Sponsor:** PictureRx, LLC
- **Collaborators:** National Institute on Minority Health and Health Disparities (NIMHD)
- **Conditions:** Health Behavior, Medication Adherence
- **Start Date:** 2011-11
- **Completion Date:** 2012-05
- **CT.gov Last Update:** 2012-06-19

## Brief Summary

This randomized controlled trial seeks to test the effect of reformatted prescription drug container labels, compared to usual labels, on participants' understanding of their medications. The study will also assess the effect on self-efficacy and self-reported medication adherence. English and Spanish speaking patients are eligible, with a planned sample size of up to 500 adults.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Be at least 18 years old,
* Fluency in English or Spanish
* Manage their own prescription medicines, and
* Have recently filled at least 1 new prescription medication (e.g, a medicine or medication dose that they have not taken before) and have their new prescription bottle information with them.

Exclusion Criteria:

* Excludes health professionals (such as a doctor, nurse or pharmacist)
* Too ill to participate in an interview
* Do not have a telephone
* Having visual acuity worse than 20/50 via Rosenbaum Visual Acuity exam (eyechart)
* Persons picking up new medicines for others
* Inability to communicate in either Spanish or English
* Overt psychiatric illnesses, overt delirium or dementia
```

## Arms

- **Traditional prescription drug labels** (NO_INTERVENTION) — Routine drug labels provided by the participating pharmacies
- **Reformatted medication labels** (EXPERIMENTAL) — Prescription drug container labels that follow a new format and also include illustrations

## Interventions

- **PictureRx medication label** (BEHAVIORAL) — Reformatted medication labels that adhere to current best practices for label design and also include illustrations

## Primary Outcomes

- **Patient understanding of their medication regimen.** _(time frame: Approximately 7 days)_ — Patient understanding of the instructions for taking their medications correctly.

## Secondary Outcomes

- **Self-efficacy** _(time frame: Approximately 7 days)_
- **Self-reported adherence** _(time frame: Approximately 7 days)_

## Locations (1)

- PictureRx, LLC (SAI Interactive), Chattanooga, Tennessee, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.picturerx, llc (sai interactive)|chattanooga|tennessee|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01622686.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01622686*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*